2005 Volume 50 Issue 2 Pages 77-78
We report a case of a 64-year-old woman with hypertension. She had dizziness and palpitation without heart failure although she was taking amlodipine. Urine levels of epinephrine and norepinephrine were high and both atrial and ventricular premature contraction were frequently seen. Valsartan, angiotensin II type 1 receptor antagonist, decreased these catecholamine levels and suppressed arrhythmias in the present case without the use of other drugs such as beta-blockers or anti-arrhythmic agents. In conclusion, valsartan is one option that can be used to prevent arrhythmias as well as to control blood pressure in hypertensive patients.
